Sequestration of Bcl-2 by venetoclax sets CLL cells free from antiapoptotic constraints allowing proapoptotic molecules (such as Bim) to tilt the anergic CLL cells towards death [78]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.